Status:

TERMINATED

Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

Lead Sponsor:

Emory University

Conditions:

Non-small Cell Lung Cancer

Renal Cell Carcinoma

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

This is a pilot study of biomarker evaluation and safety of pre-incisional ketorolac for patients undergoing surgical resection for non-small cell lung cancer and renal cell carcinoma. There is signif...

Detailed Description

Surgical resection is a cornerstone of standard-of-care treatment for early-stage non-small cell lung carcinoma (NSCLC) and renal cell carcinoma (RCC). Yet despite optimal treatment, many of these pat...

Eligibility Criteria

Inclusion

  • Pathology-proven or suspected stage 1 or 2 NSCLC and Stage 3 tumor stage 3, node stage 0 (T3N0) RCC, that require surgical resection as the treatment of choice
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
  • Ability to understand and the willingness to sign an informed written consent

Exclusion

  • Individuals with pure lung ground-glass opacity (GGO) lesions or mixed GGO with \<50% solid component
  • Patients undergoing pneumonectomy
  • History of cancer in the 3 years prior to surgery (except for basal-cell carcinoma of the skin or cervical neoplasia).
  • Contraindication for NSAIDs, including peptic ulcer disease, preoperative chronic kidney disease with estimated glomerular filtration rate (eGFR) \<45, allergies or intolerance to NSAIDs, coagulation disorder, or age \> 80 years
  • Having taken an NSAID within 5 days prior to surgery
  • Immunocompromised status
  • Refusal or inability to understand the protocol and consent form or to receive follow-up in line with the recommendations
  • Preoperative hemoglobin \< 9.0

Key Trial Info

Start Date :

August 24 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2024

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT04495894

Start Date

August 24 2020

End Date

February 1 2024

Last Update

March 4 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Emory University Hospital Midtown

Atlanta, Georgia, United States, 30308

2

Emory Clinic

Atlanta, Georgia, United States, 30322

3

Emory University Hospital

Atlanta, Georgia, United States, 30322

4

Winship Cancer Institute

Atlanta, Georgia, United States, 30322